Activation of Wnt/β-catenin pathway in monocytes derived from chronic kidney disease patients

Heevy Abdulkareem Musa Al-Chaqmaqchi1, Ali Moshfegh, Elham Dadfar

  • 1Department of Laboratory Medicine, Division of Experimental Cancer Medicine-Clinical Research Center, Karolinska Institutet, Stockholm, Sweden. Heevy.Al-Chaqmaqchi@ki.se

Plos One
|August 13, 2013
PubMed

Insights

Chronic kidney disease (CKD) patients show altered gene expression in monocytes, particularly involving the Wnt/β-catenin pathway. This may explain immune dysfunction and increased cardiovascular risk in CKD.

Area of Science:

  • Immunology
  • Nephrology
  • Genetics

Background:

  • Patients with chronic kidney disease (CKD) face higher risks of infections and cardiovascular diseases.
  • Monocytes are crucial for immune responses and are implicated in atherosclerosis.

Purpose of the Study:

  • To investigate gene expression profiles in monocytes from CKD patients.
  • To identify activated pathways contributing to atherosclerosis and infection susceptibility in CKD.

Main Methods:

  • Monocytes were isolated from peripheral blood of CKD patients (stages 4-5) and healthy donors.
  • Microarray gene expression profiling was performed.
  • Western blot analysis validated key pathway members.

Main Results:

  • Significant differential expression of 600 up-regulated and 272 down-regulated genes in CKD patients.
  • Inflammatory response pathways were highly expressed.
  • The Wnt/β-catenin signaling pathway was the most significantly activated pathway.

Conclusions:

  • Dysfunctional monocytes in CKD patients are linked to altered Wnt/β-catenin signaling.
  • Targeting the Wnt/β-catenin pathway could potentially improve immune function and reduce cardiovascular complications in CKD.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...